Additionally, the downregulation of NEAT1 induced the expression of N-cadherin and vimentin, but repressed that of E-cadherin, indicating that NEAT1 may inhibit the EMT process in breast cancer cells [34]. The gene discussed is CDH2; the disease is breast cancer.